Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Patient Positioning Based on a Radioactive Tracer Implanted in Patients With Localized Prostate Cancer: A Performance and Safety Evaluation

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [3]; ;  [4]; ;  [5]; ;  [1];  [6];  [1];  [4]
  1. Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven (Belgium)
  2. Navotek Medical Ltd, Yokneam (Israel)
  3. Tel Aviv Medical Center, Tel Aviv (Israel)
  4. Institute Verbeeten, Tilburg (Netherlands)
  5. TweeSteden Hospital, Tilburg (Netherlands)
  6. Department of Radiology, University Hospitals Leuven, Leuven (Belgium)

Purpose: To evaluate the performance and safety of a radiation therapy positioning system (RealEye) based on tracking a radioactive marker (Tracer) implanted in patients with localized prostate cancer. Methods and Materials: We performed a single-arm multi-institutional trial in 20 patients. The iridium-192 ({sup 192}Ir)-containing Tracer was implanted in the patient together with 4 standard gold seed fiducials. Patient prostate-related symptoms were evaluated with the International Prostate Symptom Score (IPSS) questionnaire. Computed tomography (CT) was performed for treatment planning, during treatment, and after treatment to evaluate the migration stability of the Tracer. At 5 treatment sessions, cone beam CT was performed to test the positioning accuracy of the RealEye. Results: The Tracer was successfully implanted in all patients. No device or procedure-related adverse events occurred. Changes in IPSS scores were limited. The difference between the mean change in Tracer-fiducial distance and the mean change in fiducial-fiducial distance was -0.39 mm (95% confidence interval [CI] upper boundary, -0.22 mm). The adjusted mean difference between Tracer position according to RealEye and the Tracer position on the CBCT for all patients was 1.34 mm (95% CI upper boundary, 1.41 mm). Conclusions: Implantation of the Tracer is feasible and safe. Migration stability of the Tracer is good. Prostate patients can be positioned and monitored accurately by using RealEye.

OSTI ID:
22149789
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 2 Vol. 85; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English